Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Semin Vasc Surg ; 34(3): 101-116, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34642030

RESUMO

Venous thromboembolic complications have emerged as serious sequelae in COVID-19 infections. This article summarizes the most current information regarding pathophysiology, risk factors and hematologic markers, incidence and timing of events, atypical venous thromboembolic complications, prophylaxis recommendations, and therapeutic recommendations. Data will likely to continue to rapidly evolve as more knowledge is gained regarding venous events in COVID-19 patients.


Assuntos
COVID-19 , Tromboembolia Venosa , Anticoagulantes/efeitos adversos , Humanos , Fatores de Risco , SARS-CoV-2 , Tromboembolia Venosa/diagnóstico , Tromboembolia Venosa/epidemiologia , Tromboembolia Venosa/etiologia
2.
Adv Wound Care (New Rochelle) ; 9(11): 602-611, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-33095127

RESUMO

Objective: Pediatric burns are a major source of injury and in the absence of adequate care can lead to lifelong functional loss and disfigurement. While split thickness skin autografts are the current standard of care for deep partial and full-thickness burns, this approach is associated with considerable morbidity. For this reason, alternative skin substitutes such as allografts have gained interest. Approach: In the present study, we present a case series of 30 children with various types of burns treated with dehydrated human amnion chorion membrane (dHACM). Results: We show that treatment with dHACM is associated with an excellent rate of healing comparable to split thickness skin grafts with less rate of hypertrophic scar and contracture. Innovation: Treatment with dHACM is particularly attractive as it consists of many tissue regenerative factors, such as growth factors and immune modulators, thus it will reduce the risk of scaring. Conclusion: While dHACM is associated with an increased upfront cost, treating patients with small to moderate-sized burns with dHACM in their regional centers works to decrease downstream costs such as management of prolonged pain from donor-site morbidity, revisional surgeries from scar and contractures of split thickness grafts, and avoiding the cost of transfer to higher level centers of care. Our findings challenge the current standard of care, suggesting that dHACM provides an alternative to the current use of split thickness skin grafting and is a safe, feasible, and potentially superior substitute for the management of small to moderate total body surface area partial and full-thickness pediatric burns.


Assuntos
Âmnio , Queimaduras/cirurgia , Córion , Adolescente , Superfície Corporal , Criança , Pré-Escolar , Desidratação , Feminino , Hospitais Pediátricos , Humanos , Lactente , Masculino , New York , Estudos Retrospectivos , Transplante de Pele , Pele Artificial , Transplante Homólogo , Resultado do Tratamento , Cicatrização
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...